CJC-1295 No DAC + Ipamorelin

CJC-1295 No DAC + Ipamorelin – Multi-Compound Research Formulation

Discover the CJC-1295 No DAC + Ipamorelin blend – a popular research combination of two high-purity research compounds. CJC-1295 No DAC serves as a short-acting GHRH analog, while Ipamorelin acts as a selective ghrelin mimetic. Together, they form a synergistic multi-compound formulation commonly used in controlled scientific studies.

Key Benefits

• Supports efficient handling of multiple research compounds in a single blend
• Provides a stable formulation for research protocols requiring precise compound combinations
• Designed for consistent performance in laboratory and research workflows
• Offers a balanced multi-compound option for researchers working with complex mixtures
• Allows convenient dosing and storage in scientific applications

How It Works

CJC-1295 No DAC and Ipamorelin are combined into one formulation, delivering complementary research properties in a single blend. This approach supports researchers working with multi-compound materials rather than handling individual components separately.

Research Snapshot

• Based on established research compounds with decades of individual study data
• Popular in scientific communities exploring multi-compound research formulations
• Preclinical and observational data available for the individual components
• Widely used in research settings requiring complex compound combinations

Why Choose Our CJC-1295 No DAC + Ipamorelin?

• Third-party tested purity
• GMP-compliant sourcing
• Often blended for convenient research use
• Transparent research-grade quality

Ready to add this research formulation to your studies? Add to Cart now. Limited supply — secure yours today!

For research/educational purposes only.